Coronary Artery Disease And Melatonin: The Mechanisms and Therapeutic Applications.
Study Goal
The researchers aimed to evaluate melatonin's potential in delaying atherosclerosis, reducing cardiac ischemia-reperfusion injury, and its therapeutic efficacy in coronary artery disease (CAD).
Results Summary
The study found that melatonin exhibits anti-inflammatory and antioxidant properties, showing promising therapeutic potential in CAD, though some key questions remain unresolved.
Population
Coronary artery disease (CAD) patients and animal models.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Melatonin (MLT) | neutral | anti-inflammatory and antioxidant properties | - | - | possesses | #1 |
Melatonin (MLT) | neutral | coronary artery disease (CAD) | CAD patients | - | rendering it a promising candidate for clinical application | #2 |
Melatonin (MLT) | neutral | - | animal models | - | elucidated the regulatory mechanisms | #3 |
Melatonin (MLT) | neutral | coronary artery disease (CAD) | - | - | preliminarily demonstrated the excellent therapeutic potential | #4 |
Melatonin (MLT) | neutral | coronary artery disease (CAD) | - | - | present compelling evidence supporting its efficacy | #5 |
Delaying the formation of atherosclerosis and reducing cardiac ischemia-reperfusion injury remain pressing issues. Melatonin (MLT) possesses anti-inflammatory and antioxidant properties, rendering it a promising candidate for clinical application in coronary artery disease (CAD) patients. While numerous in vivo experiments have elucidated the regulatory mechanisms of MLT in animal models and clinical trials have preliminarily demonstrated the excellent therapeutic potential of MLT in CAD, several key questions remain unanswered. In this review, the authors elucidate the mechanisms underlying CAD's occurrence, progression, and prognosis; delineate the pathways through which MLT exerts its effects; and present compelling evidence supporting its efficacy in CAD. In addition, the authors also describe unresolved issues in the treatment of CAD with MLT, thus providing scholars with directions for future research.